Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Sparta's i.v. formulation of busulfan enters phase I

March 25, 1997

Tokyo University researchers characterize new steroidal saponin

March 25, 1997

Daiichi discloses new antitumor agents

March 25, 1997

Preliminary phase I results for annamycin

March 21, 1997

Targretin enters phase II for diabetes

March 21, 1997

Matrix files NDA ammendment for AccuSite

March 21, 1997

U.S. researchers discover protein that inhibits apoptosis

March 21, 1997

Tumor-suppressing gene identified by scientists at Northwest Hospital

March 20, 1997

Antitumor/antiviral distamycin derivatives from P&U

March 19, 1997

Corixa and SmithKline Beecham collaborate on vaccine research

March 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...